首页> 美国卫生研究院文献>Springer Open Choice >Association Between Lipids Lipoproteins Composition of HDL Particles and Triglyceride-Rich Lipoproteins and LCAT and CETP Activity in Post-renal Transplant Patients
【2h】

Association Between Lipids Lipoproteins Composition of HDL Particles and Triglyceride-Rich Lipoproteins and LCAT and CETP Activity in Post-renal Transplant Patients

机译:肾移植术后患者脂质HDL颗粒的脂蛋白组成和富含甘油三酸酯的脂蛋白之间的关联以及LCAT和CETP活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

High-density lipoprotein (HDL) remodeling within the plasma compartment and the association between lecithin-cholesterol acyltransferase (LCAT) and cholesterol ester transfer protein (CETP) activity, and lipid, lipoprotein concentrations and composition were investigated. The aim was to examine the high sensitivity of C-reactive protein (hsCRP), lipid, apolipoprotein B (apoB), apoAI, total apoAII, apoAIInonB, apoB-containing apoAII (apoB:AII), total apoCIII, apoCIIInonB, apoB-containing apoCIII (apoB:CIII) concentration and LCAT and CETP activity to gain an insight into the association between them and LCAT and CETP, 57 post-renal transplant (Tx) patients with and without statin therapy and in 15 healthy subjects. Tx patients had moderate hypertriglyceridemia, hypercholesterolemia, and dyslipoproteinemia, disturbed triglyceride-rich lipoproteins (TRLs) and HDL composition, decreased LCAT, and slightly increased hsCRP but no CETP activity. Spearman’s correlation test showed the association between lipids and lipoproteins and LCAT or CETP, and multiple ridge stepwise forward regression showed that immunosuppressive therapy in Tx patients can disturb HDL and TRLs composition. The results suggest that inhibition or activation of LCAT is due, in part, to HDL-associated lipoprotein. Lipoprotein composition of apoAI, apoAIInonB, and apoCIIInonB in HDL particle and apoB:AII TRLs can contribute to decrease LCAT mass in Tx patients. Tx patients without statin and with lower triglycerides but higher HDL cholesterol concentration and disturbed lipoprotein composition of ApoAI and apoAII in HDL particle can decrease LCAT, increase LDL cholesterol, aggravate renal graft, and accelerate atherosclerosis and chronic heart diseases.
机译:研究了血浆区室中的高密度脂蛋白(HDL)重塑以及卵磷脂-胆固醇酰基转移酶(LCAT)和胆固醇酯转移蛋白(CETP)活性与脂质,脂蛋白浓度和组成之间的关系。目的是检查C反应蛋白(hsCRP),脂质,载脂蛋白B(apoB),apoAI,总apoAII,apoAIInonB,含apoB的apoAII(apoB:AII),总apoCIII,apoCIIInonB,含apoB的高敏感性在15位健康受试者中,采用apoCIII(apoB:CIII)浓度以及LCAT和CETP活性来了解它们与LCAT和CETP之间的关联,共有57名接受或未接受他汀类药物治疗的肾移植(Tx)患者。 Tx患者患有中度高甘油三酸酯血症,高胆固醇血症和脂蛋白异常,富含甘油三酸酯的脂蛋白(TRL)和HDL组成紊乱,LCAT降低,hsCRP略微升高,但没有CETP活性。 Spearman的相关性测试表明脂质和脂蛋白与LCAT或CETP之间存在关联,多脊逐步前移回归表明Tx患者的免疫抑制疗法可干扰HDL和TRL的组成。结果表明,LCAT的抑制或活化部分归因于HDL相关脂蛋白。 HDL颗粒和apoB:AII TRL中apoAI,apoAIInonB和apoCIIInonB的脂蛋白组成可有助于减少Tx患者的LCAT量。没有他汀类药物但甘油三酯含量较低但HDL胆固醇浓度较高且HDL颗粒中的ApoAI和apoAII脂蛋白组成受到干扰的Tx患者可以降低LCAT,增加LDL胆固醇,加重肾移植,并加速动脉粥样硬化和慢性心脏病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号